HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung Woon Paik Selected Research

clevudine

3/2013A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment.
6/2011A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B.
3/2011Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy.
5/2007Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
1/2007Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy.
5/2006A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung Woon Paik Research Topics

Disease

96Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2003
49Neoplasms (Cancer)
10/2022 - 08/2002
34Chronic Hepatitis B
11/2021 - 06/2005
26Fibrosis (Cirrhosis)
01/2022 - 03/2004
18Infections
11/2021 - 01/2003
16Chronic Hepatitis C
11/2021 - 03/2006
14Hepatitis B
01/2020 - 01/2003
12Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 06/2002
12Neoplasm Metastasis (Metastasis)
01/2019 - 08/2002
10Thrombosis (Thrombus)
01/2022 - 06/2005
10Liver Neoplasms (Liver Cancer)
10/2020 - 03/2006
7Non-alcoholic Fatty Liver Disease
01/2022 - 09/2005
7Liver Diseases (Liver Disease)
12/2017 - 06/2004
6Disease Progression
02/2021 - 12/2008
5Pancreatic Neoplasms (Pancreatic Cancer)
04/2007 - 08/2002
4Liver Abscess
04/2015 - 06/2005
4Lymphatic Metastasis
05/2014 - 09/2002
4Adenocarcinoma
06/2013 - 03/2004
3Hypertension (High Blood Pressure)
01/2022 - 01/2020
3End Stage Liver Disease
03/2021 - 01/2011
3Ascites
01/2019 - 05/2014
3Thrombocytopenia (Thrombopenia)
01/2019 - 11/2004
3Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 12/2004
3Hemorrhage
09/2014 - 09/2002
3Carcinogenesis
10/2005 - 09/2002
3Pain (Aches)
08/2004 - 11/2003
2Anorexia
10/2022 - 01/2019
2Carcinoma (Carcinomatosis)
01/2022 - 09/2002
2Obesity
01/2022 - 01/2020
2Viremia
11/2019 - 01/2017
2Hyperthermia
08/2017 - 01/2016
2Suppuration
07/2016 - 06/2005
2Necrosis
09/2014 - 12/2009
2Fatty Liver
06/2013 - 11/2005
2Acute Kidney Injury (Acute Renal Failure)
12/2011 - 09/2009
2Hepatitis A (Hepatitis, Infectious)
12/2011 - 09/2009
2Hepatitis C
03/2011 - 06/2005
2Autoimmune Hepatitis
01/2010 - 09/2005
2Chronic Kidney Failure (Chronic Renal Failure)
02/2005 - 01/2003

Drug/Important Bio-Agent (IBA)

23Antiviral Agents (Antivirals)IBA
08/2021 - 05/2006
22DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2005
17Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 06/2005
17Hepatitis B e AntigensIBA
01/2020 - 06/2005
13alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 11/2003
12Alanine Transaminase (SGPT)IBA
01/2022 - 05/2010
12Lamivudine (Epivir)FDA Link
12/2017 - 06/2005
11Ribavirin (Virazole)FDA LinkGeneric
12/2017 - 03/2006
9AlbuminsIBA
01/2022 - 03/2004
9Sorafenib (BAY 43-9006)FDA Link
01/2022 - 03/2013
8BilirubinIBA
01/2022 - 08/2002
8entecavirFDA Link
10/2021 - 06/2011
7InterferonsIBA
01/2020 - 06/2008
6Proteins (Proteins, Gene)FDA Link
03/2015 - 08/2002
6clevudineIBA
03/2013 - 05/2006
5peginterferon alfa-2a (Pegasys)FDA Link
01/2016 - 06/2005
5acarboxyprothrombin (PIVKA)IBA
03/2015 - 06/2013
5Alkaline PhosphataseIBA
01/2015 - 11/2003
5adefovirIBA
06/2014 - 05/2009
4Immunoglobulin G (IgG)IBA
01/2020 - 01/2003
4AntigensIBA
01/2015 - 02/2004
4Biological ProductsIBA
12/2014 - 08/2002
4Serum AlbuminIBA
02/2014 - 12/2010
4RNA (Ribonucleic Acid)IBA
05/2010 - 09/2002
3lenvatinibIBA
10/2022 - 02/2021
3Tenofovir (Viread)FDA Link
10/2021 - 12/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 11/2004
3Vitamin KFDA Link
03/2015 - 06/2013
3Coloring Agents (Dyes)IBA
02/2012 - 05/2004
3adefovir dipivoxil (Hepsera)FDA Link
02/2012 - 06/2005
3AntibodiesIBA
06/2011 - 08/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2004 - 08/2002
2Fetal Proteins (Fetoprotein)IBA
01/2022 - 09/2014
2Tumor Biomarkers (Tumor Markers)IBA
04/2020 - 01/2008
2daclatasvirIBA
12/2017 - 01/2016
2Pharmaceutical PreparationsIBA
11/2016 - 12/2010
2Interferon-alpha (Interferon Alfa)IBA
11/2016 - 06/2005
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2016 - 02/2013
2Biomarkers (Surrogate Marker)IBA
09/2016 - 06/2005
2Transaminases (Aminotransferases)IBA
11/2015 - 06/2013
2Triglycerides (Triacylglycerol)IBA
01/2015 - 11/2005
2LDL CholesterolIBA
01/2015 - 11/2005
2SodiumIBA
02/2013 - 01/2011
2Capsules (Microcapsules)IBA
06/2012 - 07/2006
2lipoarabinomannan (LAM)IBA
08/2011 - 12/2010
2Hepatitis A AntibodiesIBA
06/2011 - 01/2011
2Anti-Bacterial Agents (Antibiotics)IBA
06/2005 - 09/2002
2EnzymesIBA
02/2005 - 08/2002
2ParaffinIBA
03/2004 - 04/2002

Therapy/Procedure

56Therapeutics
10/2022 - 05/2004
21Radiotherapy
01/2022 - 03/2005
20Radiofrequency Ablation
10/2020 - 03/2005
12Liver Transplantation
08/2021 - 06/2002
9Hepatectomy
04/2018 - 06/2004
6Drug Therapy (Chemotherapy)
10/2022 - 11/2004
4Aftercare (After-Treatment)
07/2016 - 06/2005
4Conformal Radiotherapy
08/2010 - 06/2005
3Duration of Therapy
01/2015 - 08/2004
2Electrodes (Electrode)
07/2016 - 06/2005
2Ligation
09/2014 - 09/2002
2Surgical Instruments (Clip)
06/2011 - 03/2006